中间体和化学品
| No. | Product name | Cas No. | Usage |
| D001 | Ethyl-3-(N，N-dimethylamino) Acrylate | 924-99-2 | Ciprofloxacin |
| D002 | 2，4-Dichloro-5-fluorobenzoyl chloride | 86393-34-2 | |
| D003 | Ethyl 3-(cyclopropylamino)-2-(2，4-dichloro-5-fluoro benzyl) acrylate | 86483-53-6 | |
| D004 | 2，3，4，5-Tetrafluorobenzoyl Chloride | 94695-48-4 | Ofloxacin |
| D005 | DL-Alaninol | 6168-72-5 | |
| D006 | Norfloxacin Hydrochloride | 104142-93-0 | Norfloxacin |
| D007 | 2-Methyl-4-(1，1，1，2，3，3，3，-heptafluoro-2-propyl)aniline | 238098-26-5 | Flubendiamide |
| D008 | (1R，2R)-2-(3，4-difluorophenyl)cyclopropane-1-carboxamide | 1006376-62-0 | Ticagrelor |
| D009 | (1R，2S)-2-(3，4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate | 376608-71-8 | |
| D010 | (1R trans)-2-(3，4-difluorophenyl)cyclopropane amine | 1156491-10-9 | |
| D011 | Cyclopropanamine，2-(3，4-difluorophenyl)-(1R，2S) -(2R，3R)-2，3-dihydroxybutanedioate (1:1) | 220352-39-6 | |
| D012 | CarbaMicacid，N-[(3aS，4R，6S，6aR)-tetrahydro-6-hydroxy-2，2-diMethyl-4H-cyclopenta-1，3-dioxol-4-yl]-，phenylMethyl ester | 274693-53-7 | |
| D013 | N-[(3aS，4R，6S，6aR)-Tetrahydro-6-(2-hydroxyethoxy)-2，2-dimethyl-4H-cyclopenta-1，3-dioxol-4-yl]carbamic acid phenylmethyl ester | 274693-54-8 | |
| D014 | 2-((3aR，4S，6R，6aS)-6-amino-2，2-dimethyltetrahydro-3aH-cyclopenta[d][1，3]dioxol-4-yloxy)ethanol L-tataric acid | 376608-65-0 | |
| D015 | 4，6-Dichloro-2-propylthiopyrimidine-5-amine | 145783-15-9 | |
| D016 | 2-[[(3aR，4S，6R，6aS)-6-[[5-amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2，2-dimethyl-4H-cyclopenta-1，3-dioxol-4-yl]oxy]-ethanol | 376608-74-1 | |
| D017 | (S)-2-Chloro-1-(2，4-Dichlorophenyl) ethanol | 126534-31-4 | Luliconazole |
| D018 | (R)-3-Amino-1-butanol | 61477-40-5 | Dolutegravir |
| D019 | 1-(2，2-Dimethoxyethyl)-1，4-dihydro-3-methoxy-4-oxo-2，5-pyridinedicarboxylic acid 2-methyl ester | 1335210-23-5 | |
| D020 | 2，4-Difluorobenzylamine | 72235-52-0 | |
| D021 | L-Prolinamide | 7531-52-4 | Vildagliptin |
| D022 | (2S)-N-(Chloroacetyl)-2-Pyrrolidine Carbonitrile | 42933-44-8 | |
| D023 | 3-Amino-1-hydroxyadamantane | 702-82-9 | |
| D024 | 4-Fluoro-2-Methoxy-5-nitroaniline | 1075705-01-9 | AZD9291 |
| D025 | 2，4，5-Trifluorobenzoic acid | 446-17-3 | Delafloxacin |
| D026 | Ethyl 2，4，5-trifluorobenzoylacetate | 98349-24-7 | |
| D027 | 3，5-Difluoropyridine-2，6-diamine | 247069-27-8 | |
| D028 | 3-Hydroxyazetidine hydrochloride | 18621-18-6 | |
| D029 | Methyl 2-oxo-4-phenylpyrrolidine-3-carboxylate | 55790-17-5 | Phenibut |
| D030 | 4-Amino-3-phenylbutiric acid HCl | 3060-41-1 | |
| D031 | 3-Pyridinecarbaldehyde | 500-22-1 | Xanomeline |
| D032 | (1R,2S,5S)-methyl-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylate hydrochloride | 565456-77-1 | Nirmatrelvir |
| D033 | -methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2 -oxopyrrolidin-3-yl)propanoate | 328086-60-8 | |
| D034 | (S)-2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanamide hydrochloride | 2628280-48-6 | |
| D035 | (1R,2S,5S)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | 2755812-45-2 | |
| D036 | Ethyl 4,6-dichloropyrridazine-3-carboxylate | 679406-03-2 | Deucravacitinib |
| D037 | Methyl 4,6-dichloropyridazine-3-carboxylate | 372118-01-9 | |
| D038 | 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline | 1609394-10-6 | |
| D039 | 3-(2-Methylphenyl)-2-((Z)-propylimino)thiazolidin-4-one | 854107-53-2 | Ponesimod |
| D040 | 3-Chloro-4-[(2R)-2,3-dihydroxypropoxy]benzaldehyde | 1563017-36-6 | |
| D041 | Methyl (2R,3R,4S)-3-acetamido-4-guanidino-2-((S)-methoxy ((R)-2-oxo-1,3-dioxolan-4-yl)methyl)-3,4-dihydro-2H-pyran-6-carboxylate | 1072449-92-3 | Laninamivir |
| D042 | Methyl (2R,3R,4S)-3-acetamino-4-azido-2-((S)-methoxy((R)-2 -oxo-1,3-dioxolan-4-yl)methyl)-3,4-dihydro-2H-pyran-6-carboxylate | 1442873-91-7 | |
| D043 | Methyl (2R,5R,6R)-5-acetylamino-4-amino-6-[(S)-methoxy- ((R)-2-oxo-[1,3]dioxolan-4-yl)methyl]-5,6-dihydro-4H-pyran-2-carboxylate | 1072449-88-7 | |
| D044 | (R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-onehydrochloride | 1190363-45-1 | Rimegepant |
| D045 | (5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine dihydrochloride | 1373116-04-1 | |
| D046 | (3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidine-3-aminium 4-nitrobenzoate | 1456803-37-4 | Ubrogepant |
| D047 | (S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid | 1375541-21-1 | |
| D048 | (S)-2-(piperazin-2-yl)acetonitrile dihydrochloride | 2158301-19-8 | Adagrasib (MRTX849) |
| D049 | 2-Isopropyl-4-methylpyridin-3-amine | 1698293-93-4 | Sotorasib (AMG510) |
| D050 | 7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | 2300966-23-6 | |
| D051 | (S)-4-N-Boc-2-methylpiperazine | 147081-29-6 | |
| D052 | 2-Fluoro-6-hydroxyphenylboronic acid | 1256345-60-4 | |
| D053 | 8-Boc-3,8-diaza-bicyclo[3.2.1]octane | 149771-44-8 | MRTX1133 |
| D054 | 2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-[(E)-phenyldiazenyl]pyrimidine-4,6-diamine | 1350653-29-0 | Vireciguant |
| D055 | 3-AMino-5-fluoro-1H-pyrazolo[3,4-b]pyridine | 1034667-22-5 | |
| D056 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | 1428243-26-8 | Upadacitinib |
| D057 | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl este | 1869118-24-0 | |
| D058 | tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate | 1201187-44-1 | |
| D059 | 3-Chloro-2-pyrazinemethanamine hydrochloride | 939412-86-9 | Acalabrutinib |
| D060 | (2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester | 142078-88-1 | |
| D061 | 4-(Pyridin-2-yl)aminocarboylphenylborinic acid | 850568-25-1 | |
| D062 | (3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride | 1062580-52-2 | Tofacitinib |
| D063 | (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid compd. with (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine | 477600-71-8 | |
| D064 | Carbamic acid, N-[cis-3-(methylamino)cyclobutyl]-phenylmethyl ester, hydrochloride (1:1) | 2204290-99-1 | Abrocitinib |
| D065 | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 | |
| D066 | (R)-1-benzyl-5-methyl-1,4-diazepane | 1620097-06-4 | Suvorexant |
| D067 | 2-(2H-1,2,3-triazol-2-yl)-5-methylbenzoic acid | 956317-36-5 | |
| D068 | Pyridine-3-sulfonyl chloride Hydrochloride | 16133-25-8 | Vonoprazan |
| D069 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | 881674-56-2 | |
| D070 | 4-acetyl-2-methylbenzoic acid | 55860-35-0 | Fluralaner |
| D071 | 2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride | 1171331-39-7 | |
| D072 | 3',5'-Dichloro-2,2,2-trifluoroacetophenone | 130336-16-2 | |
| D073 | 4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methylbenzoic acid | 864725-62-2 | |
| D074 | 4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methyl tert-butyl benzoate | 1164268-79-4 | |
| D075 | (S)-4-Ethyl-4-Hydroxy-7,8-Dihydro -1H-Pyrano [3,4-F] Indolizine-3,6,10 (4H)-Trione | 110351-94-5 | Exatecan |
| D076 | N-(8-Amino-6-fluoro-5- methyl-1-oxo-1,2,3,4- tetrahydronaphthalen-2-yl) acetamide | 182182-31-6 | |
| D077 | 1-(3-MethoxyphenylL) Piperazine | 16015-71-7 | Letermovir |
| D078 | 1-(3-Methoxyphenyl)piperazine dihydrochloride | 16015-70-6 | |
| D079 | 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo -1,2,3,4-tetrahydroquinazolin-4-yl) acetic acid methyl ester | 917389-21-0 | |
| D080 | 2-(2,7-Dichloro-9H-fluorenyl-4-yl)oxirane | 53221-14-0 | Lumefantrine |
| D081 | Fluorene | 86-73-7 | |
| D082 | 2,7-Dichloroflurene | 7012-16-0 | |
| D083 | 4-Hydroxy-7-phenoxyisoquinoline-3-carboxylic acid methyl ester | 1455091-10-7 | Roxadustat |
| D084 | 5-(piperazin-1-yl)pyridin-2-amine | 1082876-26-3 | Ribociclib |
| D085 | 2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | 1211443-58-1 | |
| D086 | tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 | |
| D087 | Tert-Butyl(1R,2S,5S)-2-azido-5-[(diMethylaMino)carbonyl] cyclohexylcarbaMate oxalic acid | 1210348-34-7 | Edoxaban |
| D088 | 4,5,6,7-tetrahydro-5-methyl-Thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | 720720-96-7 | |
| D089 | 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | 1243308-37-3 | |
| D090 | Naphthalene-1,4-dione | 130-15-4 | Atovaquone |
| D091 | 5-Bromo-2-chloro-4’-ethoxydiphenylmethane | 461432-23-5 | Dapagliflozin |
| D092 | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 | |
| D093 | [(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate | 461432-25-7 | |
| D094 | 2-Chloro-5-iodobenzoic acid | 19094-56-5 | Empagliflozin |
| D095 | (S)-4-bromo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene | 915095-89-5 | |
| D096 | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Disclaimer:
Products protected under valid patents are neither offered nor supplied for any commercial use. However， the research quantities of such products may be offered for the purpose of regulatory submissions， wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
| No. | Product name | Cas No. |
| F001 | 1,2,3-1H-Triazole | 288-88-0 |
| F002 | 1,3-Dihydroxyadamantane | 5001-18-3 |
| F003 | 1,3-Dimethyl-2-Imidazolidinone ( DMI ) | 80-73-9 |
| F004 | 1,4-Naphthoquinone | 130-15-4 |
| F005 | 1,5-Pentanediol | 111-29-5 |
| F006 | 1-Fluoro Naphthalene | 321-38-0 |
| F007 | 2- Naphthol （β-Naphthol） | 135-19-3 |
| F008 | 2,2,4-Trichloro Acetophenone | 4252-78-2 |
| F009 | 2,4-Diamino-6-Chloro Pyrimidine | 156-83-2 |
| F010 | 2,4-Dichloro Acetophenone | 2234-16-4 |
| F011 | 2,4-Dichlorophenol | 120-83-2 |
| F012 | 2,6-Dichlorophenol | 87-65-0 |
| F013 | 2,6-Dichlorotoluene | 118-69-4 |
| F014 | 2,6-Dihydroxy Benzoic Acid | 303-07-1 |
| F015 | 2-Amino-5-Nitrothiazole | 121-66-4 |
| F016 | 2-Chloro-1,4-Naphthoquinone | 121-66-4 |
| F017 | 2-Chloro-5-Chloromethylpyridine (CCMP) | 70258-18-3 |
| F018 | 2-Chlorobenzonitrile | 873-32-5 |
| F019 | 2-Chlorotoluene | 95-49-8 |
| F020 | 2-Methyl Imidazole | 693-98-1 |
| F021 | 2-Methyl Propionyl Chloride (Isobutyryl Chloride) | 79-30-1 |
| F022 | 2-Nitroimino Imidazolidine(NII) | 5465-96-3 |
| F023 | 3-Chloro-2-Methyl Aniline | 87-60-5 |
| F024 | 3-Chloro-4-Fluoro Aniline (CFA) | 367-21-5 |
| F025 | 3'-Chloropropiophenone | 34841-35-5 |
| F026 | 3-Methyl-4-nitrobenzoic acid | 3113-71-1 |
| F027 | 4,6-Dimethoxy-2-(methylsulfonyl)pyrimidine, MSDP | 38452-46-9 |
| F028 | 4-Amino-2-chloropyridine | 14432-12-3 |
| F029 | 4-Chloro-2-nitrotoluene | 89-59-8 |
| F030 | 4-Chlorotoluene | 106-43-4 |
| F031 | 5-Cyano Indole | 15861-24-2 |
| F032 | 5-Fluoro Cytosine | 2022-85-7 |
| F033 | 8-Hydroxy Quinoline | 148-24-3 |
| F034 | Acetophenone | 98-86-2 |
| F035 | Allylamine HCl | 10017-11-5 |
| F036 | Amitraz 98% Min | 33089-61-1 |
| F037 | Ammonium Thiocyanate | 1762-95-4 |
| F038 | Cyanoacetic Acid | 372-09-8 |
| F039 | Cyclopentyl Chloride | 930-28-9 |
| F040 | Cytosine | 71-30-7 |
| F041 | D - Mandelic Acid | 611-71-2 |
| F042 | D (-) Tartaric Acid | 526-83-0 |
| F043 | Decane | 124-18-5 |
| F044 | Diisopropyl azodicarboxylate | 2446-83-5 |
| F045 | Dimethyl Carbonate (DMC) | 616-38-6 |
| F046 | Dimethyl sulfoxide | 67-68-5 |
| F047 | Dimethylmalonic acid | 595-46-0 |
| F048 | Divinyl Benzene ( DVB) | 1321-74-0 |
| F049 | Dodecyl /Tetradecyl Dimethylamine （DMA） | 84649-84-3 |
| F050 | Ethoxy Methylene Malonic Diethyl Ester (EMME) | 87-13-8 |
| F051 | Fluorene | 86-73-7 |
| F052 | Fluoro Benzene | 462-06-6 |
| F053 | Gallic Acid (Anhydrous & Monohydride) | 149-91-7 |
| F054 | Glyoxylic acid | 298-12-4 |
| F055 | Guanyl Thiourea | 2114-02-5 |
| F056 | Imidazole | 288-32-4 |
| F057 | Indoline | 496-15-1 |
| F058 | Isobutenyl sulfide | N/A |
| F059 | Isovaleraldehyde | 590-86-3 |
| F060 | L (+) Tartaric Acid | 87-69-4 |
| F061 | L-4-Thiazolylalanine | 119433-80-6 |
| F062 | Maleic Anhydride | 108-31-6 |
| F063 | Meta Hydroxy Acetophenone | 121-71-1 |
| F064 | Mono N Butylamine | 109-73-9 |
| F065 | N-Ethyl piperazine | 5308-25-8 |
| F066 | N-Methyl piperazine | 109-01-3 |
| F067 | N-Octyl-D-Glucamine, NODG | 23323-37-7 |
| F068 | Ortho Chloro Benzoic Acid (OCBA) | 118-91-2 |
| F069 | Ortho Chloro Benzyl Cyanide | 2856-63-5 |
| F070 | Ortho Hydroxy Acetophenone | 118-93-4 |
| F071 | Ortho Phenylene diamine (OPDA) | 95-54-5 |
| F072 | Ortho Chlorophenol | 95-57-8 |
| F073 | Para Chlorophenol | 106-48-9 |
| F074 | Para Amino Acetophenone | 99-92-3 |
| F075 | Para Anisoyl Chloride | 100-07-2 |
| F076 | Para Chloro Benzyl Cyanide | 140-53-4 |
| F077 | Para Cyano Phenol | 767-00-0 |
| F078 | Para Hydroxy Acetophenone | 99-93-4 |
| F079 | Para Nitro Benzoic acid | 62-23-7 |
| F080 | Phenyl Hydrazine HCl | 59-88-1 |
| F081 | Piperazine Anhydrous | 110-85-0 |
| F082 | Propionyl Chloride ( PPC) | 79-03-8 |
| F083 | Propyl Gallate | 121-79-9 |
| F084 | Pyridine-3-carbaldehyde | 500-22-1 |
| F085 | R (+) -1-Phenyl Ethylamine | 3886-69-9 |
| F086 | Raspberry Ketone | 5471-51-2 |
| F087 | S - Mandelic Acid | 17199-29-0 |
| F088 | S(-) -1-Phenyl Ethylamine | 2627-86-3 |
| F089 | Salicylaldehyde | 90-02-8 |
| F090 | Sodium Borohydride | 16940-66-2 |
| F091 | Sulfamide | 7803-58-9 |
| F092 | Tetrahydrofuran(THF) | 109-99-9 |
| F093 | Tetrahydrofurfuryl alcohol | 97-99-4 |
| F094 | Thiophene | 110-02-1 |
| F095 | Thiourea | 62-56-6 |
| F096 | Triethyl Ortho Formate (TEOF) | 122-51-0 |
| F097 | Trimethyl Ortho Formate (TMOF) | 149-73-5 |
| F098 | Triphosgene | 32315-10-9 |
| No. | Product name | CAS No. | Structure |
| G001 | 2,3-二氨基吡啶 2,3-Diaminopyridine | 452-58-4 |  |
| G002 | 六氟二酐 4,4'-(Hexafluoroisopropylidene) diphthalic anhydride | 1107-00-2 |  |
| G003 | 2,6-萘二胺 2,6-Diaminonaphthalene | 2243-67-6 |  |
| G004 | 1,6-萘二胺 1,6-Diaminonaphthalene | 2243-63-2 |  |
| G005 | 2,6-二羟基间苯二甲酸 2,6-Dihydroxyterephthalic acid | 69660-39-5 |  |
| G006 | 4-二甲氨基哌啶盐酸盐 N,N-Dimethylpuperidine-4-amino hydrochloride | 50533-97-6 |  |
| G007 | N,N,N’-三甲基乙二胺 N,N,N’-Trimethylethylenediamine | 142-25-6 |  |
| G008 | 萘-1,6-二甲酸 Naphthalene-1,6-dicarboxylic acid | 2089-87-4 |  |
| G009 | 4,4’-二羟基二苯醚 4,4'-Oxydiphenol | 1965-09-9 |  |
| G010 | 6-羟基-2-萘甲酸 6-Hydroxy-2-naphthoic acid | 16712-64-4 |  |
| G011 | 5-氟-2-甲氧基苯甲酸 5-Fluoro-2-methoxybenzoic acid | 394-04-7 |  |
| G012 | 4,4'-二(4-氨基苯氧基)联苯 4,4'-Bis(4-aminophenoxy)biphenyl | 13080-85-8 |  |
| G013 | 2,2'-二(三氟甲基)二氨基联苯 2,2'-Bis(trifluoromethyl)benzidine | 341-58-2 |  |
| G014 | 4,4'-二氨基联苯-2,2'-二羧酸 4,4'-Diaminobiphenyl-2,2’-dicarboxylic acid | 17557-76-5 |  |
| G015 | 9,9-二(3-氟-4-氨基苯基)芴 9,9-Bis(4-amino-3-fluorophenyl)fluorene | 127926-65-2 |  |
| G016 | 9,9-双(4-氨基苯基)芴 9,9-Bis(4-aminophenyl)fluorene | 15499-84-0 |  |
| G017 | 2,2-双(3-氨基-4-羟基苯基)六氟丙烷 2,2-Bis(3-amino-4-hydroxyphenyl) hexafluoropropane | 83558-87-6 |  |
| G018 | 三乙烯二胺 Triethylenediamine | 280-57-9 |  |
Disclaimer:
Products protected under valid patents are neither offered nor supplied for any commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
| No. | Product name | CAS No. | Structure |
| H001 | 2-氨基-5-碘吡啶 2-Amino-5-iodopyridine | 20511-12-0 |  |
| H002 | 2,6-萘二酚 2,6-Naphthalenediol | 581-43-1 |  |
| H003 | 6-溴-2-氨基萘 6-Bromonaphthalen-2-amine | 7499-66-3 |  |
| H004 | 4-吡啶-4-基苯甲酸 4-Pyrid-4-ylbenzoic acid | 4385-76-6 |  |
| H005 | 6-羟基-1-萘甲酸 6-Hydroxy-1-naphthoic acid | 2437-17-4 |  |
| H006 | 1,3-二溴苯 1,3-Dibromobenzene | 108-36-1 |  |
| H007 | 1-氨基环丙烷羧酸 1-Aminocyclopropane carboxylic acid | 22059-21-8 |  |
| H008 | 3-溴联苯 3-Bromobiphenyl | 2113-57-7 |  |
| H009 | 3-氨基联苯 3-Aminobiphenyl | 2243-47-2 |  |
| H010 | 3,5-二羟基苯甲醛 3,5-Dihydroxybenzaldehyde | 26153-38-8 |  |
| H011 | 4’-羟基联苯-4-羧酸 4’-Hydroxy-4-biphenylcarboxylic acid | 58574-03-1 |  |
| H012 | 间三联苯 1,3-diphenylbenzene | 92-06-8 |  |
| H013 | 1,3,5-三溴苯 1,3,5-Tribromobenzene | 626-39-1 |  |
| H014 | 乙烯硼酐吡啶络合物 2,4,6-Trivinylcyclotriboroxane pyridine complex | 95010-17-6 |  |
| H015 | 2-甲氧基-4,4,5,5-四甲基-1,3,2-二氧硼戊环 2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 1195-66-0 |  |
| H016 | 4,4’-二溴二苯醚 Bis(4-bromophenyl) ether | 2050-47-7 |  |
| H017 | 异丙醇频哪醇硼酸酯 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 61676-62-8 |  |
| H018 | 6-溴-2-萘酚 6-Bromo-2-naphthol | 15231-91-1 |  |
| H019 | 6-氨基-萘-2-醇 6-Amino-2-naphthalenol | 4363-04-6 |  |
| H020 | 1,6-二溴萘 1,6-Dibromonaphthalene | 19125-84-9 |  |
| H021 | 二苯基富烯 Diphenylfulvene | 2175-90-8 |  |
| H022 | 4-羟基-4’-甲氧基联苯 4-Hydroxy-4’-methoxybiphenyl | 16881-71-3 |  |
| H023 | 2-氯咔唑 2-Chloro-9H-carbazole | 10537-08-3 |  |
| H024 | 3-氯咔唑 3-Chloro-9H-carbazole | 2732-25-4 |  |
| H025 | 1,6-二溴芘 1,6-Dibromopyrene | 27973-29-1 |  |
| H026 | N-乙烯基咔唑 N-Vinylcarbazole | 1484-13-5 |  |
| H027 | 4-溴-4’-(二苯氨基)联苯 4-(4-Bromophenyl)-N,N-diphenyl aniline | 202831-65-0 |  |
| H028 | 4-氨基-2-氯吡啶 4-Amino-2-chloropyridine | 14432-12-3 |  |
| H029 | 9,9’-双(6-羟基-2-萘基)芴 9,9’-Bis(6-hydroxy-2-naphthyl)fluorene | 934557-66-1 |  |
| H030 | 1-溴-3,5-二苯基苯 1-Bromo-3,5-diphenylbenzene | 103068-20-8 |  |
Disclaimer:
Products protected under valid patents are neither offered nor supplied for any commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.